Learn To Draw
|
| Live Cycling News | ||
Lance Armstrong Stars in Leadville 100 Special In-Theater Event on October 22 Lance Armstrong and other top cyclists race onto the big screen in a grueling quest to reach the finish line. Source : Lance Armstrong to Promote Michelob Ultra 7-time Tour de France winner and cycling icon Lance Armstrong has signed an agreement with Michelob Ultra/Anheuser Busch to become the brand’s new ambassador. Source : Lance Armstrong to be spokesman for Michelob Ultra (AP) Cycling great Lance Armstrong has inked a deal with Anheuser-Busch InBev to be the spokesman for the company's Michelob Ultra brand of beer. The seven-time winner of the Tour de France and the brewer announced the three-year deal Tuesday. Armstrong will appear in two television ads featuring the brand, and his image will be in outdoor, print and in-store advertising and possibly packaging. Source : Riders used new drugs at Tour de France • Hematide was used to stabilise haemoglobin levels• Aicar enhances muscle tissue while burning fat Two new, undetectable doping products were used at this year's Tour de France, according to the French Anti-Doping Agency. Pierre Bordry, head of the AFLD, told Le Monde that "two new products were used during [this year's] Tour de France: two medicines that are not yet on the market." One of the new products, according to the newspaper, is Hematide, which is a form of erythropoietin (EPO), that maintains stable haemoglobin levels – fluctuating haemoglobin readings being one indicator that an athlete has doped. The other product allegedly used is Aicar, which enhances muscle tissue while burning fat. Bordry was reportedly "shocked" by the thinness of some of the riders at this year's Tour. The possible use of Hematide by athletes carries echoes of the Cera cases at the 2008 Tour. Then a test for Cera – a so-called third generation EPO – was developed in secret in collaboration with the product's manufacturer and used on riders' samples. Hematide is still undergoing clinical tests and it could be another two years before it is approved to treat anaemic patients – which, like other forms of EPO, including Cera, is its intended medical use. The AFLD is likely to carry out retrospective tests on stored samples from the 2008 and 2009 races. Bordry said he believes illegal blood transfusions – for which there is a test – were still in use at this year's Tour, and he claimed that his agency had found evidence of "hardcore medicines" in rubbish bins during the Tour, including "a substance for producing insulin that is normally used by diabetics." It has been a busy week for Bordry and the AFLD, who today are expected to announce the results of the latest batch of re-testing on samples from the 2008 Tour. They have not said what the new tests are for, though it has been claimed that they have targeted riders who finished in the top 20. Other reports have said that up to 40 riders were identified as suspicious, while the Italian sports daily Gazzetta dello Sport alleged that samples from 15 of the race's top 20 finishers have been re-tested. Cycling Tour de France Drugs in sport Richard Moore guardian.co.uk © Guardian News & Media Limited 2009 | Use of this content is subject to our Terms & Conditions | More Feeds show enclosure (image/jpeg) Source : Italy's Bosisio banned for positive dope test Italian cyclist Gabriele Bosisio is provisionally suspended after testing positive for EPO in an out of competition test last month, the International Cycling Union said in a statement. Source : BRIEF-Cycling-Italy's Bosisio banned for positive dope test (Reuters) Italian cyclist Gabriele Bosisio has been provisionally suspended after testing positive for EPO in an out of competition test last month, the International Cycling Union (UCI) said in a statement on Tuesday. Source :
|
|
